Truist Financial Cuts Privia Health Group (NASDAQ:PRVA) Price Target to $28.00

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price lowered by Truist Financial from $32.00 to $28.00 in a report issued on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also recently issued reports on PRVA. Jefferies Financial Group began coverage on […]

Leave a Reply

Your email address will not be published.

Previous post Algert Global LLC Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Next post Sources: Patriots offer free-agent WR Kendrick Bourne contract, AFC East suitors may loom